Boston Scientific Announces First Patient Active with LATITUDE(TM) NXT Remote Patient Management System
Boston Scientific Corp.
One Boston Scientific Place
Natick, MA, 01760
Press release date: June 14, 2012
NATICK, Massachusetts and PARIS -- Next-generation wireless remote patient management system enabled for INGENIO(TM) family of pacemakers is now in use in Europe
Boston Scientific Corporation (NYSE: BSX) has initiated use of the LATITUDE NXT Remote Patient Management System with patients in Europe.
Dr. Roberto Verlato, head of cardiology at Camposampiero Hospital in Verona, Italy initiated use of the LATITUDE NXT system with a patient implanted with an INGENIO(TM) SR pacemaker, and provided the patient with a new home-based wireless communicator.
"We welcome the next-generation LATITUDE NXT system as it provides pacemaker patients with a simple and easy-to-use communicator that may replace certain in-clinic follow-up visits. The system offers clinicians the most comprehensive suite of diagnostic tools in the CRM industry to support proactive treatment decisions and provide an opportunity to verify improvement of clinical outcomes, as was demonstrated for ICD and CRT-D patients in the ALTITUDE Survival study," said Dr. Verlato.
The LATITUDE NXT website and patient communicator merge key features from the trusted LATITUDE system with new features requested by physicians and patients, and is fully compatible with Boston Scientific's advanced pacemaker family: INGENIO and ADVANTIO(TM) pacemakers and INVIVE(TM) cardiac resynchronization therapy pacemakers (CRT-P).
LATITUDE NXT offers patients a simplified experience with wireless and automatic remote follow-up and optional integrated cellular GSM connectivity, providing patients with greater convenience than existing systems. In addition, LATITUDE NXT features a unique communicator-initiated device interrogation which is designed to minimize impact on implanted device battery longevity, potentially giving patients greater peace of mind.
LATITUDE NXT offers health care professionals a system that provides convenient online access to relevant pacemaker patient information, and flexibility and control in how clinicians receive and review data. The LATITUDE NXT system features alert notification options such as SMS message or email, simple website administration, and integration with the hospital medical database (electronic medical records, or EMR) to automate hospital workflow - which could save up to 15 minutes for each patient transmission, the average time it takes to manually enter routine device follow-up data into an EMR system.
LATITUDE NXT is compatible with the wireless weight scale and blood pressure monitor from Boston Scientific. Physicians can choose to remotely monitor a series of relevant health status indicators including weight and blood pressure, as well as respiratory and sleep apnea trending. By providing access to this diagnostic information, LATITUDE NXT enables physicians to risk-stratify patients to more confidently make informed, proactive treatment decisions.
"We are proud to enhance the level of support available to pacemaker patients by offering the state-of-the-art LATITUDE NXT system. An increasing percentage of patients needing cardiac rhythm therapy are indicated for pacemakers, and we are pleased to continue to innovate technology to support positive patient outcomes and quality of life," said Michael Onuscheck, senior vice president and president of EMEA for Boston Scientific.
Pacemakers are designed to treat bradycardia, a condition in which the heart beats too slowly - usually less than 60 beats per minute - depriving the body of sufficient oxygen.
For more news about Boston Scientific at Cardiostim 2012, please follow us on Twitter @bsc_eu_heart (https://twitter.com/#!/BSC_EU_Heart).
The LATITUDE NXT Remote Patient Management System is currently under review by the U.S. Food and Drug Administration and is currently not available for sale in the United States.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.
Source: Boston Scientific Corporation
Contact: Simonetta Balbi, +39-3387936422 (mobile), PR and Corporate Communication EMEA, Boston Scientific Balbis@bsci.com; Sabrina Gomersall, +44-2031166476 (office), +44-7803295221 (mobile), Director WCG, email@example.com; Sean Wirtjes, +1-508-652-5305 (office); Steven Campanini, +1-508-652-5740 (office), Media Relations, Boston Scientific Corporation, firstname.lastname@example.org